Chemotherapy in recurrent ependymoma

Pediatric Neurosurgery

Volumn 28, Issue 6, 1998, Pages 314-319

  Siffert, Joao ^a   Allen, Jeffrey C ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Brain tumor; Chemotherapy; Ependymoma; Glioma; Radiotherapy

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FUMAGILLOL CHLOROACETYLCARBAMATE; IPROPLATIN; LEFLUNOMIDE; LOBRADIMIL; MELPHALAN; PLATELET DERIVED GROWTH FACTOR; PROCARBAZINE; RECOMBINANT BETA INTERFERON; THIOTEPA; TOPOTECAN; UNCLASSIFIED DRUG;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TOXICITY; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG INDUCED DISEASE; EPENDYMOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS; EPENDYMOMA; HUMANS; INFANT; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL;

EID: 0031689364     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028669     Document Type: Review

References (29)

1. Healey E, Barnes P, Kupsky W, Scott R: The prognostic significance of postoperative residual tumors in ependymoma. Neurosurgery 1991;28:666-672.
2. Nazar G, Hoffman H, Becker L, Jenkin D, Humphreys R, Hendrick E: Infratentorial ependymomas in childhood: Prognostic factors and treatment. J Neurosurg 1990;72:408-417.
3. Dohrmann G, Farwell J, Flannery J: Ependymomas and ependymoblastomas in children. J Neurosurg 1976;45:273-283.
4. Mork S, Lokn A: Ependymoma. A follow-up study of 101 cases. Cancer 1977;40:907-915.
5. Pierre-Kahn A, Hirsch J, Roux F, Renier D, Sainte-Rose C: Intracranial ependymomas in childhood. Survival and functional results of 47 cases. Child's Brain 1983;10:145-156.
6. Cohen M, Duffner P: Brain Tumors in Children, ed 2. New York, Raven, 1994.
7. Goldwein J, Corn B, Finlay J, Packer R: Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas? Cancer 1991;67:2766-2771.
8. Kovalic J, Flaris N, Grigsby P, Pirkowski M, Simpson J, Roth K: Intracranial ependymoma: Long term outcome, patterns of failure. J Neurooncol 1993;15:125-131.
9. Evans AE, Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL: Adjuvant chemotherapy of childhood posterior fossa ependymoma: Cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: A Childrens Cancer Group study. Med Pediatr Oncol 1996;27:8-14.
10. Weitman S, Ochoa S, Sullivan J, Sinister J, Winick N, Pratt C, Vietti T, Harris M: Pediatric phase II cancer chemotherapy trials: A Pediatric Oncology Group study. J Pediatr Hematol Oncol 1997,19:187-191.
11. Wilson C, Guttin P, Boldrey E, Crafts D, Levin V, Enot K: Single-agent chemotherapy of brain tumors. Arch Neurol 1976;33:739-744.
12. Allen JC, Hancock C, Walker R, Tan C: PCNU and recurrent childhood brain tumors. J Neurooncol 1987,5:241-244.
13. Walker R, Allen J: Cisplatin in the treatment of recurrent childhood primary brain tumors. J Clin Oncol 1988;6:62-66.
14. Bertolone S, Baum E, Krivit W, Hammond G: A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Group. J Neurooncol 1989;7:5-11.
15. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD Hammond GD: Carboplatin in childhood brain tumors. A Children's Cancer Study Group phase II trial. Cancer 1990;66:2465-2469.
16. Friedman HS, Krischer JP, Burger P, Oakes WJ, Hockenberger B, Weiner MD, Falletta JM, Norris D, Ragab AH, Mahoney DH, Whitehead M, Kun LE: Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: A Pediatric Oncology Group randomized phase II study. J Clin Oncol 1992;10:249-256.
17. Allen JC, Packer RJ, Bleyer A: Recombinant interferon beta: A phase I-II trial in children with recurrent brain tumors. J Clin Oncol 1991;9:783-788.
18. Heideman RL, Packer RJ, Reaman GH, Allen JC, Lange B, Horowitz ME, Steinberg SM, Gillespie A, Kovnar EH, Balis FM, Poplack DG: A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 1993;72:271-275.
19. Abrahamsen T, Lange B, Packer R, Venzon D, Allen J, Craig C, Patronas N, Katz D, Goldwein J, DeLaney T, Reaman G, Perilongo G, Philhps P, Oldfield E, Poplack D, Horowitz M: A phase I and II trial of dose-intensified cyclophosphamide and GM-CSF in pediatric malignant brain tumors. J Pediatr Hematol Oncol 1995;17:134-139.
20. Needle MN, Mollowy PT, Geyer JR, Herman-Liu A, Belasco JB, Goldwein JW, Sutton L, Phillips PC: Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors. Med Pediatr Oncol 1997;29:28-32.
21. Friedman H, Oakes W: The chemotherapy of posterior fossa tumors in childhood. J Neurooncol 1987;5:217-229.
22. van Eys J, Baram T, Cangir A, Bruner J. Martinez-Prieto J: Salvage chemotherapy for recurrent primary brain tumors in children. J Pediatr 1988;113:601-606.
23. Corden B, Strauss L, Killmond T, Carson B, Wharam M, Kumar A, Piantadose S, Robb P, Phillis P: Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors. J Neurooncol 1991;11:57-63.
24. Chastagner P, Kalifa C, Gentet J, Doz F: Phase II study of cyclophosphamide (CTX) and etoposide (VP-16) in children with recurrent brain tumors (abstract 434). Proc ASCO 1992;11:153.
25. Heideman R, Kuttesch J, Stewart C, Meyer W, Bowman L, Furman W, Gajjar A, Avery L, Pratt C: A phase I trial of a fixed systemic exposure (AUC) of carboplatin with continuous infusion topotecan in pediatric solid tumors. Proc ASCO 1995;14:A1430.
26. Mahoney DH, Strother D, Camitta B, Bowen T, Ghim T, Pick T, Wall D, Yu L, Shuster J, Friedman H: High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: A pilot Pediatric Oncology Group study. J Clin Oncol 1996;14:382-388.
27. Graham ML, Herndon JE II, Casey JR, Chaffee S, Giocci GH, Drischer JP, Kurtzberg J, Laughling MJ, Longee DC, Olson JF, Paleologus N, Pennington CN, Friedman HS: High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol 1997;15:1814-1823.
28. Grill J, Kalifa C, Doz F, Schoepfer C, Sainte-Rose C, Couanet D, Terrier-Lacombe TJ, Valteau-Couanet D, Hartmann O: A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. Pediatr Neurosurg 1996;25:7-12.
29. Chou PM, Sanz CR, Tomita T, Reyes-Mugica M: Ependymomas in children express the multidrug resistance gene: Immunohistochemical and molecular biologic study. Pediatr Pathol Lab Med 1996;16:551-561.